Hakan Öztürk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hakan Öztürk has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Odul Egritas
Gazi University Pediatric Eosinophilic Gastrointestinal Diseases Working Group Ankara Türkiye
8 shared publications - Sinan Sari
Division of Pediatric Gastroenterology, Gazi University School of Medicine, Ankara, Türkiye
7 shared publications - Buket Dalgıç
Gazi University Pediatric Eosinophilic Gastrointestinal Diseases Working Group Ankara Türkiye
6 shared publications Buket Dalgıç
4 shared publications- Demet Teker Düztaş
Department of Pediatric Gastroenterology, Ankara Etlik City Hospital, 06170 Ankara, Türkiye
4 shared publications - Arzu Bakirtas
Department of Pediatric Allergy, Gazi University Faculty of Medicine, Ankara, Türkiye
3 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Galenos Yayinevi in Gazi Medical Journal
Seasonal Variation in Histologic and Endoscopic Activity of Pediatric Eosinophilic Esophagitis: A Repeated Endoscopy Cohort
Seasonal Variation in Histologic and Endoscopic Activity of Pediatric Eosinophilic Esophagitis: A Repeated Endoscopy Cohort - Gazi Medical Journal
- 15 October 2026
- Published by Galenos Yayinevi in Gazi Medical Journal
Open AccessSeasonal Variation in Histologic and Endoscopic Activity of Pediatric Eosinophilic Esophagitis: A Repeated Endoscopy Cohort
Seasonal Variation in Histologic and Endoscopic Activity of Pediatric Eosinophilic Esophagitis: A Repeated Endoscopy Cohort - Gazi Medical Journal
- Open Access
- 18 August 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (8) , e70467
Behind the scenes: Primary immunodeficiencies in pediatric eosinophilic gastrointestinal diseases
Background: Primary immunodeficiencies (PIDs) and eosinophilic gastrointestinal diseases (EGIDs) may share common underlying defects. However, no studies have investigated the frequency of PIDs among patients with EGIDs. In this study, we aimed to assess the frequency and spectrum of PIDs among our pediatric EGIDs patients. Method: Patients were prospectively evaluated over a two‐year period. All patients were questioned according to ten warning signs of the Jeffrey Model Foundation. Routine laboratory tests and basic immunologic tests [serum immunoglobulin levels, isohemagglutinin titres, anti‐HBs and anti‐rubella Ig G titres] were performed on all participants. Advanced immunologic workup was performed in selected cases. All PID diagnoses were established according to the European Society for Immunodeficiencies' criteria. Electronic health records were screened for EGIDs' specific features, comorbidities, and previous laboratory tests. Results: A total of 88 EGID patients [76% male, mean age: 12.02 years, 78 patients (88.6%) with EoE] were included. Fourteen patients were diagnosed with predominantly antibody deficiencies [unclassified antibody deficiency ( n = 11), selective Ig A deficiency ( n = 2), transient hypogammaglobulinemia of infancy ( n = 1)]. Eighteen patients had abnormal Ig levels. Comparisons across the groups revealed no statistically significant differences in demographic, endoscopic, and pathologic features. Only topical swallowed budesonide unresponsiveness was significantly higher among cases with PID ( p = .004). Conclusion: PIDs may not be rare among patients with EGIDs. JMF's warning signs alone may be insufficient to identify affected patients in this population; therefore, additionally, basic immunologic tests as first step and advanced evaluation in suspected cases may be appropriate. Neither the key diagnostic endoscopic and pathological features nor the presence of strictures reliably distinguish PIDs. image
- 18 August 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (8) , e70467
Open AccessBehind the scenes: Primary immunodeficiencies in pediatric eosinophilic gastrointestinal diseases
Background: Primary immunodeficiencies (PIDs) and eosinophilic gastrointestinal diseases (EGIDs) may share common underlying defects. However, no studies have investigated the frequency of PIDs among patients with EGIDs. In this study, we aimed to assess the frequency and spectrum of PIDs among our pediatric EGIDs patients. Method: Patients were prospectively evaluated over a two‐year period. All patients were questioned according to ten warning signs of the Jeffrey Model Foundation. Routine laboratory tests and basic immunologic tests [serum immunoglobulin levels, isohemagglutinin titres, anti‐HBs and anti‐rubella Ig G titres] were performed on all participants. Advanced immunologic workup was performed in selected cases. All PID diagnoses were established according to the European Society for Immunodeficiencies' criteria. Electronic health records were screened for EGIDs' specific features, comorbidities, and previous laboratory tests. Results: A total of 88 EGID patients [76% male, mean age: 12.02 years, 78 patients (88.6%) with EoE] were included. Fourteen patients were diagnosed with predominantly antibody deficiencies [unclassified antibody deficiency ( n = 11), selective Ig A deficiency ( n = 2), transient hypogammaglobulinemia of infancy ( n = 1)]. Eighteen patients had abnormal Ig levels. Comparisons across the groups revealed no statistically significant differences in demographic, endoscopic, and pathologic features. Only topical swallowed budesonide unresponsiveness was significantly higher among cases with PID ( p = .004). Conclusion: PIDs may not be rare among patients with EGIDs. JMF's warning signs alone may be insufficient to identify affected patients in this population; therefore, additionally, basic immunologic tests as first step and advanced evaluation in suspected cases may be appropriate. Neither the key diagnostic endoscopic and pathological features nor the presence of strictures reliably distinguish PIDs. image
- Open Access
- 20 March 2026
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (4) , 344-351
Pediatric Quality of Life Inventory™ Eosinophilic Esophagitis Module: Evaluating validity and reliability in Turkish Children and Their Parents
Objective: The Pediatric Quality of Life Inventory™ (PedsQL™) Eosinophilic Esophagitis (EoE) Module is a specialized instrument designed to assess how EoE affects the quality of life in pediatric patients. This study assesses the Turkish cross-cultural adaptation of the 8-12-year-old version. Materials and Methods: As part of the cross-cultural adaptation of the Turkish PedsQL™ EoE Module for children aged 8-12 (Tr-PedsQL™ EoE), linguistic validation, content validity (CnV), construct validity (CsV), and reliability testing were conducted. The CsV was evaluated by correlating Tr-PEESS v2.0 Frequency and Total scores with the Tr-PedsQL™ EoE Symptoms Total, Symptoms I, and Symptoms II scores. Reliability was assessed using Cronbach’s alpha for internal consistency and intraclass correlation coefficients (ICC) for test-retest stability. Results: The study included 25 children diagnosed with EoE and their parents (n=25). All items showed CnV indexes above 0.8. Good to excellent correlations (r=−0.459 to −0.948) between Tr-PEESS v2.0 (Frequency, Total) and Tr-PedsQL™ EoE Module (Total, Symptoms Total, Symptoms I-II) scores indicate CV. The 8-12-year-old version showed good to excellent internal consistency, with Cronbach's α values of 0.712-0.918 for children and 0.703-0.901 for parents. All ICCs indicated good to excellent test-retest reliability (0.777-0.905 for children, 0.801-0.941 for parents). Conclusion: Validity and reliability analyses confirmed that the Tr-PedsQL™ EoE Module is a psychometrically sound instrument for use in both children and their parents. It completed the cross-cultural adaptation process and is appropriate for implementation in both clinical practice and research contexts in Türkiye.
- 20 March 2026
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (4) , 344-351
Open AccessPediatric Quality of Life Inventory™ Eosinophilic Esophagitis Module: Evaluating validity and reliability in Turkish Children and Their Parents
Objective: The Pediatric Quality of Life Inventory™ (PedsQL™) Eosinophilic Esophagitis (EoE) Module is a specialized instrument designed to assess how EoE affects the quality of life in pediatric patients. This study assesses the Turkish cross-cultural adaptation of the 8-12-year-old version. Materials and Methods: As part of the cross-cultural adaptation of the Turkish PedsQL™ EoE Module for children aged 8-12 (Tr-PedsQL™ EoE), linguistic validation, content validity (CnV), construct validity (CsV), and reliability testing were conducted. The CsV was evaluated by correlating Tr-PEESS v2.0 Frequency and Total scores with the Tr-PedsQL™ EoE Symptoms Total, Symptoms I, and Symptoms II scores. Reliability was assessed using Cronbach’s alpha for internal consistency and intraclass correlation coefficients (ICC) for test-retest stability. Results: The study included 25 children diagnosed with EoE and their parents (n=25). All items showed CnV indexes above 0.8. Good to excellent correlations (r=−0.459 to −0.948) between Tr-PEESS v2.0 (Frequency, Total) and Tr-PedsQL™ EoE Module (Total, Symptoms Total, Symptoms I-II) scores indicate CV. The 8-12-year-old version showed good to excellent internal consistency, with Cronbach's α values of 0.712-0.918 for children and 0.703-0.901 for parents. All ICCs indicated good to excellent test-retest reliability (0.777-0.905 for children, 0.801-0.941 for parents). Conclusion: Validity and reliability analyses confirmed that the Tr-PedsQL™ EoE Module is a psychometrically sound instrument for use in both children and their parents. It completed the cross-cultural adaptation process and is appropriate for implementation in both clinical practice and research contexts in Türkiye.
- Open Access
- 16 January 2026
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 36 (2026) , 1-8
The Impact of the COVID-19 Pandemic on Pediatric Endoscopy Practices: A Single-Center Experience
Aim: This study aimed to evaluate the impact of the Coronavirus disease 2019 (COVID-19) pandemic on pediatric endoscopy practice, focusing on changes in procedure volume, prioritization, and implementation. Additionally, safety approaches adopted in response to evolving clinical conditions during the pandemic were assessed.Materials and Methods: Children aged 0–18 years who underwent endoscopy at Gazi University Faculty of Medicine, Department of Pediatric Gastroenterology between March 2019 and February 2022 were retrospectively reviewed. The study period was divided into three phases: the one-year pre-pandemic period, the first year of the pandemic, and the second year of the pandemic. Endoscopy volume, indications, procedure types, and COVID-19–related practices were compared across these periods.Results: A total of 1,283 pediatric endoscopic procedures were analyzed, including 617 performed in the pre-pandemic period, 215 during the first pandemic year, and 451 during the second pandemic year. During this period, the proportion of procedures performed for urgent and very urgent indications increased, while elective procedures declined significantly (p = 0.0028). Despite the marked reduction in overall endoscopy volume, the relative proportions of diagnostic and interventional procedures remained stable across the study periods (p = 0.230). The overall diagnostic yield increased significantly during the first pandemic year compared with the pre-pandemic period (74.0% vs. 48.8%, p <0.001), likely reflecting both the predominance of indications with higher pre-test probability and the restriction of presentations to patients with more severe symptoms. In the second pandemic year, endoscopy volume increased markedly compared with the first year, and the distribution of indications shifted toward a profile closer to the pre-pandemic period. No confirmed SARS-CoV-2 transmission was detected among patients or healthcare workers following endoscopic procedures performed under infection control measures.Conclusions: The COVID-19 pandemic led to substantial reorganization of pediatric endoscopy practice. While procedure volumes declined and urgent indications predominated during the early phase of the pandemic, endoscopic activity gradually normalized as deferred procedures were rescheduled. Our findings suggest that pediatric endoscopy can be performed safely and sustainably during extraordinary conditions when appropriate prioritization and infection control measures are applied.
- 16 January 2026
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 36 (2026) , 1-8
Open AccessThe Impact of the COVID-19 Pandemic on Pediatric Endoscopy Practices: A Single-Center Experience
Aim: This study aimed to evaluate the impact of the Coronavirus disease 2019 (COVID-19) pandemic on pediatric endoscopy practice, focusing on changes in procedure volume, prioritization, and implementation. Additionally, safety approaches adopted in response to evolving clinical conditions during the pandemic were assessed.Materials and Methods: Children aged 0–18 years who underwent endoscopy at Gazi University Faculty of Medicine, Department of Pediatric Gastroenterology between March 2019 and February 2022 were retrospectively reviewed. The study period was divided into three phases: the one-year pre-pandemic period, the first year of the pandemic, and the second year of the pandemic. Endoscopy volume, indications, procedure types, and COVID-19–related practices were compared across these periods.Results: A total of 1,283 pediatric endoscopic procedures were analyzed, including 617 performed in the pre-pandemic period, 215 during the first pandemic year, and 451 during the second pandemic year. During this period, the proportion of procedures performed for urgent and very urgent indications increased, while elective procedures declined significantly (p = 0.0028). Despite the marked reduction in overall endoscopy volume, the relative proportions of diagnostic and interventional procedures remained stable across the study periods (p = 0.230). The overall diagnostic yield increased significantly during the first pandemic year compared with the pre-pandemic period (74.0% vs. 48.8%, p <0.001), likely reflecting both the predominance of indications with higher pre-test probability and the restriction of presentations to patients with more severe symptoms. In the second pandemic year, endoscopy volume increased markedly compared with the first year, and the distribution of indications shifted toward a profile closer to the pre-pandemic period. No confirmed SARS-CoV-2 transmission was detected among patients or healthcare workers following endoscopic procedures performed under infection control measures.Conclusions: The COVID-19 pandemic led to substantial reorganization of pediatric endoscopy practice. While procedure volumes declined and urgent indications predominated during the early phase of the pandemic, endoscopic activity gradually normalized as deferred procedures were rescheduled. Our findings suggest that pediatric endoscopy can be performed safely and sustainably during extraordinary conditions when appropriate prioritization and infection control measures are applied.
- Open Access
- 1 September 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 60 (5) , 524-530
Long-Term Impact of the Coronavirus Disease 2019 Pandemic on Children with Eosinophilic Esophagitis
Objective: Although a limited number of studies have assessed the impact of the Coronavirus disease 2019 (COVID-19) pandemic on adults with eosinophilic esophagitis (EoE), there are no data on children. This study aimed to assess the impact of the COVID-19 pandemic on children with EoE, including long-term follow-up, treatment adherence, COVID-19 infection, and vaccination status. Materials and Methods: Treatment adherence, symptoms, and endoscopic-pathological findings were compared at the beginning and the end of the first and second years of the pandemic. The COVID-19 infection and vaccination status were also assessed. Results: The study included 66 children (median age 13.2 years) with EoE. Both treatment adherence and endoscopic follow-up decreased significantly during the pandemic compared to the beginning (P < .001 and P < .001, respectively). No strictures were observed. Twentytwo patients underwent endoscopy both before and during the pandemic, showing increased total eosinophilic esophagitis endoscopic reference score (EREFS) and peak eosinophil counts (P = .045 and P = .08, respectively). Among children aged 12 and older, 66% were vaccinated against COVID-19. Infection with COVID-19 was detected in 24 children (36.3%), with asymptomatic or mild symptoms in 95.8% of cases. Conclusion: No strictures developed during the first 2 years of the pandemic in children with EoE. However, increased tissue eosinophilia and EREFS scores suggest a possible risk of fibrostenosis if treatment adherence remains low. Eosinophilic esophagitis does not seem to pose an increased risk for COVID-19 infection in children. Cite this article as: Polat Terece S, Ertoy Karagöl HI, Köken G, et al. Long-term impact of the Coronavirus disease 2019 pandemic on children with eosinophilic esophagitis. Turk Arch Pediatr. 2025;60(5):524-530.
- 1 September 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 60 (5) , 524-530
Open AccessLong-Term Impact of the Coronavirus Disease 2019 Pandemic on Children with Eosinophilic Esophagitis
Objective: Although a limited number of studies have assessed the impact of the Coronavirus disease 2019 (COVID-19) pandemic on adults with eosinophilic esophagitis (EoE), there are no data on children. This study aimed to assess the impact of the COVID-19 pandemic on children with EoE, including long-term follow-up, treatment adherence, COVID-19 infection, and vaccination status. Materials and Methods: Treatment adherence, symptoms, and endoscopic-pathological findings were compared at the beginning and the end of the first and second years of the pandemic. The COVID-19 infection and vaccination status were also assessed. Results: The study included 66 children (median age 13.2 years) with EoE. Both treatment adherence and endoscopic follow-up decreased significantly during the pandemic compared to the beginning (P < .001 and P < .001, respectively). No strictures were observed. Twentytwo patients underwent endoscopy both before and during the pandemic, showing increased total eosinophilic esophagitis endoscopic reference score (EREFS) and peak eosinophil counts (P = .045 and P = .08, respectively). Among children aged 12 and older, 66% were vaccinated against COVID-19. Infection with COVID-19 was detected in 24 children (36.3%), with asymptomatic or mild symptoms in 95.8% of cases. Conclusion: No strictures developed during the first 2 years of the pandemic in children with EoE. However, increased tissue eosinophilia and EREFS scores suggest a possible risk of fibrostenosis if treatment adherence remains low. Eosinophilic esophagitis does not seem to pose an increased risk for COVID-19 infection in children. Cite this article as: Polat Terece S, Ertoy Karagöl HI, Köken G, et al. Long-term impact of the Coronavirus disease 2019 pandemic on children with eosinophilic esophagitis. Turk Arch Pediatr. 2025;60(5):524-530.
- 20 June 2025
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 28 (6) , 489-494
Childhood Lupus-Associated Protein-Losing Enteropathy (LUPLE): A Case Report and Review of the Literature
Protein-losing enteropathy (PLE) is a rare condition characterized by clinical findings such as edema, ascites, pleural effusion, and diarrhea due to excessive protein loss from the gastrointestinal system. Although systemic lupus erythematosus (SLE) is rare in childhood, PLE can be the first presenting feature; this condition is referred to as lupus-associated protein-losing enteropathy (LUPLE). Protein-losing enteropathy (PLE) is an uncommon condition resulting from excessive protein loss in the gastrointestinal system. Our case shows that PLE can be the initial presentation of SLE, which is a rare manifestation in childhood. PLE, a rare complication of lupus, tends to be more severe in children, and the diagnostic process can be challenging. This case report presents a 7-year-old girl who presented with abdominal distension, generalized edema, chronic diarrhea, and weakness. Despite treatment, the recurrence of symptoms and the addition of new joint findings led to further investigations, which revealed positive anti-dsDNA and low complement levels, resulting in a diagnosis of systemic lupus erythematosus. The patient’s clinical condition improved with steroid, azathioprine, and hydroxychloroquine treatments. This case highlights the importance of considering SLE in the differential diagnosis of PLE and underscores the significance of recognizing the rare presentations of childhood lupus.
- 20 June 2025
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 28 (6) , 489-494
Childhood Lupus-Associated Protein-Losing Enteropathy (LUPLE): A Case Report and Review of the Literature
Protein-losing enteropathy (PLE) is a rare condition characterized by clinical findings such as edema, ascites, pleural effusion, and diarrhea due to excessive protein loss from the gastrointestinal system. Although systemic lupus erythematosus (SLE) is rare in childhood, PLE can be the first presenting feature; this condition is referred to as lupus-associated protein-losing enteropathy (LUPLE). Protein-losing enteropathy (PLE) is an uncommon condition resulting from excessive protein loss in the gastrointestinal system. Our case shows that PLE can be the initial presentation of SLE, which is a rare manifestation in childhood. PLE, a rare complication of lupus, tends to be more severe in children, and the diagnostic process can be challenging. This case report presents a 7-year-old girl who presented with abdominal distension, generalized edema, chronic diarrhea, and weakness. Despite treatment, the recurrence of symptoms and the addition of new joint findings led to further investigations, which revealed positive anti-dsDNA and low complement levels, resulting in a diagnosis of systemic lupus erythematosus. The patient’s clinical condition improved with steroid, azathioprine, and hydroxychloroquine treatments. This case highlights the importance of considering SLE in the differential diagnosis of PLE and underscores the significance of recognizing the rare presentations of childhood lupus.
- 10 May 2025
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (7) , 1451-1454
Prevalence of portal vein thrombosis in pediatric patients with cirrhosis and intrahepatic non-cirrhotic portal hypertension
- 10 May 2025
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (7) , 1451-1454
Prevalence of portal vein thrombosis in pediatric patients with cirrhosis and intrahepatic non-cirrhotic portal hypertension
- 29 April 2025
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 61 (7) , 1049-1055
Neonatal Cholestasis: Exploring Genetic Causes and Clinical Outcomes
Introduction: Neonatal cholestasis is a group of disorders characterised by conjugated hyperbilirubinemia in the newborns and young infants. Advances in genetic testing have facilitated the identification of specific aetiology. This study examines the genetic and clinical profiles of neonates with cholestasis, focusing on genotype–phenotype correlations and diagnostic outcomes.Methods: A retrospective review of children with neonatal cholestasis treated between 1997 and 2024 was conducted. Extrahepatic causes were excluded, and genetic testing, including a targeted cholestasis panel and whole exome sequencing (WES), was employed. Clinical and biochemical data, including gamma‐glutamyl transferase (GGT) levels, were collected.Results: Genetic disorders were identified in 28.0% of 378 cases, including mutations in ATP8B1, ABCB11, ABCB4, DCDC2, DGUOK, KIF12, USP53, and genes related to bile acid synthesis (HSD3B7, PEX1). GGT levels played a significant role in diagnosis: patients with low or normal GGT were frequently diagnosed with progressive familial intrahepatic cholestasis (PFIC)1 and 2, or bile acid synthesis defects, while high GGT levels were associated with PFIC3, alpha‐1 antitrypsin deficiency, and cystic fibrosis. Consanguinity was noted in 56.0% of genetically diagnosed cases. After 2010, 35.5% of patients received a genetic diagnosis, compared to 18.2% before 2010.Conclusion: Genetic diseases are a major cause of neonatal cholestasis, and GGT levels serve as a useful diagnostic tool in differentiating subtypes. The increasing availability of genetic testing has improved early diagnosis and personalised management. Expanded genetic testing in clinical practice is critical for timely and accurate diagnosis of these rare disorders.
- 29 April 2025
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 61 (7) , 1049-1055
Neonatal Cholestasis: Exploring Genetic Causes and Clinical Outcomes
Introduction: Neonatal cholestasis is a group of disorders characterised by conjugated hyperbilirubinemia in the newborns and young infants. Advances in genetic testing have facilitated the identification of specific aetiology. This study examines the genetic and clinical profiles of neonates with cholestasis, focusing on genotype–phenotype correlations and diagnostic outcomes.Methods: A retrospective review of children with neonatal cholestasis treated between 1997 and 2024 was conducted. Extrahepatic causes were excluded, and genetic testing, including a targeted cholestasis panel and whole exome sequencing (WES), was employed. Clinical and biochemical data, including gamma‐glutamyl transferase (GGT) levels, were collected.Results: Genetic disorders were identified in 28.0% of 378 cases, including mutations in ATP8B1, ABCB11, ABCB4, DCDC2, DGUOK, KIF12, USP53, and genes related to bile acid synthesis (HSD3B7, PEX1). GGT levels played a significant role in diagnosis: patients with low or normal GGT were frequently diagnosed with progressive familial intrahepatic cholestasis (PFIC)1 and 2, or bile acid synthesis defects, while high GGT levels were associated with PFIC3, alpha‐1 antitrypsin deficiency, and cystic fibrosis. Consanguinity was noted in 56.0% of genetically diagnosed cases. After 2010, 35.5% of patients received a genetic diagnosis, compared to 18.2% before 2010.Conclusion: Genetic diseases are a major cause of neonatal cholestasis, and GGT levels serve as a useful diagnostic tool in differentiating subtypes. The increasing availability of genetic testing has improved early diagnosis and personalised management. Expanded genetic testing in clinical practice is critical for timely and accurate diagnosis of these rare disorders.
- Open Access
- 15 March 2024
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 35 (3) , 255-261
A Classification for Gastric Outlet Obstruction in Childhood: Extending Beyond Infantile Hypertrophic Pyloric Stenosis
Background/Aims: Gastric outlet obstruction (GOO) is a rare condition in childhood, with the exception of infantile hypertrophic pyloric stenosis (IHPS). However, no classification exists from a pediatric gastroenterologists perspective. Materials and Methods: The patients with a diagnosis of GOO between 2009 and 2020 were reviewed retrospectively. We classified the patients according to GOO: presence of clinical findings accompanied by radiological and/or endoscopic findings; clinical status: intractable nonbilious postprandial vomiting alone or with abdominal pain, early satiety, weight loss, postprandial abdominal distension, and malnutrition; radiology: delayed gastric emptying and dilated stomach; endoscopy: nonbilious gastric contents after 6-8 hours of emptying and/or failed pyloric intubation; physical examination: visible gastric peristalsis. Results: A total of 30 GOO patients (15 patients with IHPS, 1 patient with annular pancreas, 4 patients with gastric volvulus, 2 patients with duodenal atresia, 2 patients with antral web, 1 patient with late-onset hypertrophic pyloric stenosis (LHPS) had surgical treatment, and remaining 5 patients had medical treatment) were enrolled to the study. The median age was 8 months (range: 3 months-16 years), and 14 patients were female. Mitochondrial disorders, LHPS, metabolic disorders, and eosinophilic gastrointestinal system diseases were added to Sharmas GOO classification, and the classification has been expanded. Conclusion: This is the first and largest study of GOO in children. From the perspective of pediatric gastroenterology, new diseases will be addressed, and definitions will be highlighted with our classification for GOO in childhood. Cite this article as: Eğritaş Grkan ö, öztrk H, Kaya C, et al. A classification for gastric outlet obstruction in childhood: Extending beyond infantile hypertrophic pyloric stenosis. Turk J Gastroenterol. 2024;35(3):255-261.
- 15 March 2024
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 35 (3) , 255-261
Open AccessA Classification for Gastric Outlet Obstruction in Childhood: Extending Beyond Infantile Hypertrophic Pyloric Stenosis
Background/Aims: Gastric outlet obstruction (GOO) is a rare condition in childhood, with the exception of infantile hypertrophic pyloric stenosis (IHPS). However, no classification exists from a pediatric gastroenterologists perspective. Materials and Methods: The patients with a diagnosis of GOO between 2009 and 2020 were reviewed retrospectively. We classified the patients according to GOO: presence of clinical findings accompanied by radiological and/or endoscopic findings; clinical status: intractable nonbilious postprandial vomiting alone or with abdominal pain, early satiety, weight loss, postprandial abdominal distension, and malnutrition; radiology: delayed gastric emptying and dilated stomach; endoscopy: nonbilious gastric contents after 6-8 hours of emptying and/or failed pyloric intubation; physical examination: visible gastric peristalsis. Results: A total of 30 GOO patients (15 patients with IHPS, 1 patient with annular pancreas, 4 patients with gastric volvulus, 2 patients with duodenal atresia, 2 patients with antral web, 1 patient with late-onset hypertrophic pyloric stenosis (LHPS) had surgical treatment, and remaining 5 patients had medical treatment) were enrolled to the study. The median age was 8 months (range: 3 months-16 years), and 14 patients were female. Mitochondrial disorders, LHPS, metabolic disorders, and eosinophilic gastrointestinal system diseases were added to Sharmas GOO classification, and the classification has been expanded. Conclusion: This is the first and largest study of GOO in children. From the perspective of pediatric gastroenterology, new diseases will be addressed, and definitions will be highlighted with our classification for GOO in childhood. Cite this article as: Eğritaş Grkan ö, öztrk H, Kaya C, et al. A classification for gastric outlet obstruction in childhood: Extending beyond infantile hypertrophic pyloric stenosis. Turk J Gastroenterol. 2024;35(3):255-261.